Nio, CVS Health Should Rise; Stellantis Weak

U.S.-listed shares of Nio (NYSE:NIO) are moving sharply higher in pre-market trading after the Chinese electric vehicle maker announced a 13.3 billion yuan investment in Nio China from strategic investors.

Healthcare company CVS Health (NYSE:CVS) may also see initial strength after a report from the Wall Street Journal said hedge fund Glenview Capital Management will meet top executives on Monday to propose ways the struggling company can improve its operations.

On the other hand, shares of Stellantis (NYSE:STLA) are seeing substantial pre-market weakness after the automaker cut its full-year adjusted operating profit margin outlook.


Posted

in

by

Tags: